The High Cost of Interventions

May 14

Healthcare reforms are igniting debate across the United States; policymakers, clinicians, and care recipients and their families alike all have differing, yet valid opinions about what needs to be done in order to avoid bankrupting the federal government and devastating family budgets.

As costs become increasingly unsustainable, further efforts to control costs are inevitable; legislation like the HITECH Act and provisions such as Meaningful Use are two examples of this. Regardless of varied opinions, most parties can agree that improving quality of care and efficiency of interventions are key platforms as we move forward with solving the current healthcare crisis.

The high cost of interventions

But How Do We Ensure Our Interventions Are Working?

And equally as important, that they are also efficient? Whether an intervention adds value to a patient’s life should be the deciding factor to ensuring high-cost interventions provide high-value to a patient’s quality of life. Several organizations have stated that proving interventions add quality of life years both at the time of said intervention, as well as downstream costs associated that follow, have been difficult to verify.

Measuring downstream costs (which can be very substantial), such as follow up appointments, additional interventions that occur as a result of the first intervention, and/or any costs that have only arisen because the initial intervention was performed, is difficult yet necessary if we are to succeed in avoiding economic and healthcare disruptions.

The high cost of interventions 2

In order to collect appropriate data regarding quality of life years from high-cost interventions, we will need to implement technology that is able to capture data at the point-of-care and can be fed into an archive which is accessible by the entire care team. Electronic Health Records, which are being funded to a total sum of $19.2 billion because of HITECH, are a step in the right direction, but do not meet the requirements needed to show interventions are working.

That is why at Mozzaz Corporation, we are diligently working to bring Mozzaz Care to market next month. Mozzaz Care, which is currently in use in its Beta phase by several organizations, captures all pieces of patient-centered data and uploads it to a Cloud that permitted parties are able to engage with. Leveraging this data allows checking of compliance against care plans as well as whether or not interventions have proven fruitful – both at time-of-intervention as well as downstream of the initial intervention.

The high cost of interventions 3

This data is of the utmost importance because it can provide considerable value to engage clinicians, policymakers, and patients in efforts to promote high-value care.

And high-value, quality care that connects a patient to their care provider and gives clinicians the tools they need to prove their care is effective, is what we advocate for.